InSitu Biologics is advancing localized sustained-release drug delivery, starting with INSB200™
#12 of 96 medical devices startups
▲ 2 since the last ranking
Ranked 6:02 AM PT · Thu, Nov 19
Listed
InSitu Biologics is advancing localized sustained-release drug delivery, starting with INSB200™, a peripheral nerve block for extended post-surgical pain relief.
If a fact is wrong, or you want the profile removed, tell us: we act on every request within 2 business days.